High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
Författare
Summary, in English
Germline mutations in the tumour suppressor gene CDKN2A occur in 5-20% of familial melanoma cases. A single founder mutation, p.Arg112dup, accounts for the majority of CDKN2A mutations in Swedish carriers. In a national program, carriers of p.Arg112dup mutation have been identified. The aim of this study was to assess cancer risks in p.Arg112dup carriers and their first degree relatives (FDRs) and second degree relatives (SDRs).
Avdelning/ar
- Bröstcancer-genetik
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Kirurgi, Lund
- EpiHealth: Epidemiology for Health
Publiceringsår
2014
Språk
Engelska
Sidor
545-552
Publikation/Tidskrift/Serie
Journal of Medical Genetics
Volym
51
Issue
8
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
BMJ Publishing Group
Ämne
- Medical Genetics
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 0022-2593